Amsterdam 2015
Menu
AIDSImpact.com
Conference Details
Authors
International Committee
Plenary Speakers
Presenting Speakers
Programme
Sessions
Scientific Committee
Acknowledgements
| Abstract #2311 - Poster 1 | ||||
|
Session: 58.28: Poster 1 (Poster) on Tuesday in Chaired by Authors: Presenting Author: dr Catherine Adams - CNWL, United Kingdom |
||||
| Additional Authors: Dr Kouassi Martin, Mr Brou Sylvain, | ||||
| Aim: To describe the numbers and diagnoses of people co-infected with HIV and Hepatitis C referred to the dedicated psychological medicine service. | ||||
| Method / Issue: A retrospective review of all cases referred to the service during 2014. Paper records of all the referrals made by GPs, clinicians and self-referrals were used to identify those that were HIV positive. The details about each referral made to both psychologists and psychiatrists were then extracted from an electronic data base and analysed. | ||||
| Results / Comments: Out of the 392 patients seen by the psychological medicine service in 2014, the number of patients referred co-infected with HIV and Hepatitis C was 34 (9%). The mean age of this group was 45, just above the average age of 43 for all referrals to the service. The principal psychiatric diagnosis of this group was depression in 16 (47%) of patients, anxiety disorder in 6 (18%) and adjustment disorder in 4 (12%). This compares similarly to the principal diagnosis of patients without hepatitis C, in which 170 (47%) also have a principal diagnosis of depression, 54 (15%) anxiety disorder and 61 (17%) have a principal diagnosis of adjustment disorder. In both the group with Hepatitis C and the group without, 9% had a principal diagnosis of substance misuse. | ||||
| Discussion: Whilst dual diagnosis patients represent a minority of patients referred to the service, their problems and diagnosis are comparable to the rest of the patients referred to the service with almost half suffering from depressive disorder. In some cases, the depressive symptoms could be caused or exacerbated by the hepatitis treatment. Therefore, mental health and medical teams need to be able to recognise the patterns of depressive features in these patients and work jointly to monitor these patients during treatment. | ||||
| Go Back | ||||